Tagged with manufacturing,

Ireland The strong flow of FDI into Ireland has led to a vibrant ecosystem of Irish service providers, who have grown up servicing the needs of pharma MNCs. Working for FDI clients has put Irish companies to the test and pushed them to work to the highest standards. “Top global pharma…

Ireland David Anchell, cofounder and CEO of Camida, a bespoke chemical supplier and distributor based in Ireland, details the exciting story of Camida’s founding, the specialist sourcing services they provide, their ‘can-do’ attitude of never saying no to clients, and his insights on the development of the Irish pharmaceutical landscape in…

Ireland Donal O’Callaghan, founder and CEO of Callaghan Engineering, an Irish engineering and construction firm, tells us what motivated him to break into the pharma market in 1990, the changes in the industry he has seen, and his ambition to position Callaghan Engineering as an engineering house of choice. You founded…

Mexico Salomon Rayek, CEO at Sinbiotik, explains how the company managed to adapt its business model to the industry trends and showcases the added value of Sinbiotik when offering high quality, cost-effective and fully regulated APIs manufactured locally. Could you please introduce yourself to our international audience as well as the…

Luxembourg Miriam Steimer, as employee number one of the Fast-track diagnostics success story, provides a thorough analysis into the company’s global footprint, the scope of operations in Luxembourg with both manufacturing and R&D activities, and the significance of the “made in Luxembourg” label. Finally, Ms Steimer shares FTD’s remarkably high levels…

Switzerland With 40 years of history in Switzerland, B Braun serves every hospital in the country and operates three distinct production sites. CEO Madeleine Stöckli discusses her strategy for improving productivity and finding opportunities for growth. Could you please briefly introduce yourself and B Braun Switzerland to our readers? B Braun…

Mexico This chart gives an insight into the phenomenal importance of the pharmaceutical industry to Mexico, in terms of both monetary value and employment created. Public, private, and out of pocket healthcare coverage in Mexico. The growth of the Mexican pharma industry by patented, generic and OTC segments. API Manufacturing compared…

Switzerland Developing manufacturing capacity for as yet unapproved drugs can create huge risk on innovators’ balance sheets, risk which can be mitigated by working instead with a competent CMO – a form of insurance as explained by Siegfried CEO Rudolf Hanko.   The CMO sector has grown faster than the pharma…

Ireland Chairman for BioPharmaChemical Ireland and Leader of Pfizer’s two small molecule API manufacturing sites in Cork, Seamus Fives recounts his team’s efforts to avert the closure of the Little Island facility through improvements in operating efficiency, and discusses how Pfizer is re-equipping their small molecule facilities to fit the needs…

Philippines Higinio “JP” Porte, president of the Philippine Pharmaceutical Manufacturers Association, discusses how his extensive pharmaceutical background led him to his current role as well as the main objectives of the association moving forward. He also discusses his work to create comradery within the association, fostering an environment where members are…

Mexico José Angel García Hinojosa, counsellor of the board of the Grupo Loeffler Russek, details how Loeffler’s impressive growth has forced the company to increase their manufacturing capacity. While Loeffler grew from a small Mexican business to one of the most prominent generics companies in the fast-growing Mexican market, Mr. García…

Switzerland Nicolas Hug reveals how UCB´s new facility in Bulle, Switzerland, is one of the largest microbial derived pharmaceuticals plants in Europe; how the key challenge for manufacturers today is to guarantee supplies by building a robust network; and why manufacturing is where dreams become reality, taking the results from a…